Non-Current Liabilities
Pfizer·Balance Sheet Statement·5 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Long-term debt | $57.5B | $58B | $57.4B | $57.6B | $57.5B | $57.4B | $61.6B | $60.6B |
| Other non-current liabilities | $16.1B | $15.6B | $14.2B | $13.3B | $13.9B | $13.6B | $14.7B | $14.2B |
| Liability For Uncertain Tax Positions Noncurrent | $6.5B | $5.9B | $6.1B | $5.7B | $3.3B | $3.4B | $3.6B | $3.7B |
| Total liabilities | $128.2B | $126.9B | $124.9B | $117.4B | $117.1B | $115.6B | $3.2B | $3.4B |
| Retirement and nonpension postretirement benefit obligations | $2B | $2.1B | $2.1B | $2B | $2.1B | $2.2B | $2B | $2B |